THE POPULATION IMPACT OF CHEMOTHERAPY IN LATE-STAGE PROSTATE CANCER: A SIMULATION STUDY USING TAX327 AND SEER-MEDICARE DATA

被引:0
|
作者
Onukwugha, E. [1 ]
Mullins, C. D.
Seal, B. [2 ]
Hussain, A. [3 ]
机构
[1] Univ Maryland, Sch Pharm, Baltimore, MD 21201 USA
[2] Sanofi Aventis, Bridgewater, NJ USA
[3] Univ Maryland, Sch Med, Baltimore, MD 21201 USA
关键词
D O I
10.1016/S1098-3015(10)73187-9
中图分类号
F [经济];
学科分类号
02 ;
摘要
引用
收藏
页码:A26 / A26
页数:1
相关论文
共 47 条
  • [21] Initial Biopsy Gleason Score as a Predictive Marker for Survival Benefit in Patients with Castration-resistant Prostate Cancer Treated with Docetaxel: Data from the TAX327 Study
    van Soest, Robert J.
    de Morree, Ellen S.
    Shen, Liji
    Tannock, Ian F.
    Eisenberger, Mario A.
    de Wit, Ronald
    EUROPEAN UROLOGY, 2014, 66 (02) : 330 - 336
  • [22] Clinical-Prostate cancer Skeletal-related events after abiraterone or enzalutamide in patients with metastatic castration-resistant prostate cancer: A population-based study using the SEER-Medicare linked dataset
    Kwon, Daniel H.
    Paciorek, Alan
    Zhang, Li
    Borno, Hala T.
    Bucknor, Matthew
    Small, Eric J.
    Aggarwal, Rahul R.
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2022, 40 (08) : 379.e17 - 379.e24
  • [23] Cancer-directed therapy and potential impact on survivals in nonresected hepatocellular carcinoma: SEER-Medicare population study (vol 13, pg 2021, 2017)
    Kokabi, Nima
    Duszak, Richard, Jr.
    Xing, Minzhi
    Howard, David H.
    Applegate, Kimberly E.
    Camacho, Juan C.
    Kim, Hyun S.
    FUTURE ONCOLOGY, 2018, 14 (03) : 307 - 307
  • [24] Clinical Impact of ASCO Choosing Wisely Guidelines on Staging Imaging for Early-Stage Breast Cancers: A Time Series Analysis Using SEER-Medicare Data
    Baltz, Alan P.
    Siegel, Eric R.
    Kamal, Arif H.
    Siegel, Robert
    Kozlik, Mary May
    Crist, Stephanie T. S.
    Makhoul, Issam
    ASCO Quality Publications Task Force
    JCO ONCOLOGY PRACTICE, 2023, 19 (02) : 95 - +
  • [25] Rate of skeletal-related events (SREs) for abiraterone acetate (AA) versus enzalutamide (ENZ) in prostate cancer: A population-based study using the SEER-Medicare database.
    Kwon, Daniel H.
    Paciorek, Alan
    Zhang, Li
    Borno, Hala
    Desai, Arpita
    Bose, Rohit
    Chou, Jonathan
    Fong, Lawrence
    Friedlander, Terence W.
    Huang, Franklin W.
    Koshkin, Vadim S.
    Small, Eric Jay
    Aggarwal, Rahul Raj
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [26] Comparison of cisplatin-versus carboplatin-based concurrent chemoradiation for limited-stage small cell lung cancer using SEER-Medicare data
    Kim, Ellen
    Biswas, Tithi
    Koroukian, Siran M.
    Dowlati, Afshin
    Sharma, Neelesh
    Machtay, Mitchell
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [27] Healthcare costs and utilization associated with pain among breast cancer survivors: a propensity score matched cohort study using SEER-Medicare data
    Mrinmayee Lakkad
    Bradley Martin
    Chenghui Li
    Sarah Harrington
    Lindsey Dayer
    Jacob T. Painter
    Journal of Cancer Survivorship, 2023, 17 : 917 - 950
  • [28] Healthcare costs and utilization associated with pain among breast cancer survivors: a propensity score matched cohort study using SEER-Medicare data
    Lakkad, Mrinmayee
    Martin, Bradley
    Li, Chenghui
    Harrington, Sarah
    Dayer, Lindsey
    Painter, Jacob T.
    JOURNAL OF CANCER SURVIVORSHIP, 2023, 17 (04) : 917 - 950
  • [29] Survival benefit associated with surgery performed by a colorectal cancer surgeon in a cohort of stage III colon cancer patients aged 65 and older: an analysis using SEER-Medicare data
    Hanna, N. N.
    Onukwugha, E.
    Mullins, D.
    ANNALS OF SURGICAL ONCOLOGY, 2010, 17 : S97 - S97
  • [30] Various prognostic nodal factors, adjuvant chemotherapy and survival among same cohort of colon cancer patient aged 65 and older: an analysis using SEER-Medicare data
    Hanna, N. N.
    Onukwugha, E.
    Choti, M.
    Davidoff, A.
    Zuckerman, I.
    Hsu, V.
    Mullins, D.
    ANNALS OF SURGICAL ONCOLOGY, 2010, 17 : S99 - S99